Axillary Nodal Evaluation in Breast Cancer: State of the Art.
Chang JM, Leung JWT, Moy L, Ha SM, Moon WK.
Radiology. 2020 Jun;295(3):500-515. doi: 10.1148/radiol.2020192534. Epub 2020 Apr 21.
Is axillary lymph node clearance required in node-positive breast cancer?
Bundred NJ, Barnes NL, Rutgers E, Donker M.
Nat Rev Clin Oncol. 2015 Jan;12(1):55-61. doi: 10.1038/nrclinonc.2014.188. Epub 2014 Nov 4.
Management of axillary disease.
Caudle AS, Cupp JA, Kuerer HM.
Surg Oncol Clin N Am. 2014 Jul;23(3):473-86. doi: 10.1016/j.soc.2014.03.007. Epub 2014 Apr 13.
Evaluating the role of level 3 axillary lymph node dissection in metastatic melanoma: Can we predict involvement?
Parker LM, Beekman KE, DePalo DK, Elleson KM, Zager JS.
J Surg Oncol. 2024 Jun;129(8):1515-1520. doi: 10.1002/jso.27664. Epub 2024 May 8.
Evaluation of Axillary Lymph Node Marking with Magseed before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study.
Martínez M, Jiménez S, Guzmán F, Fernández M, Arizaga E, Sanz C.
Breast J. 2022 Jul 9;2022:6111907. doi: 10.1155/2022/6111907. eCollection 2022.
Meta-analysis on axillary lymph node metastasis rate in ductal carcinoma in situ with microinvasion.
Li X, Zhou C, Xu T, Ren Y, Li M, Shang J.
Cancer Med. 2024 Jun;13(12):e7413. doi: 10.1002/cam4.7413.
Evolution in the Management of Axillary Lymph Nodes in Breast Cancer.
Wilke LG, Woodfin AA, Owusu-Brackett N, Beck AC.
Adv Surg. 2025 Sep;59(1):1-14. doi: 10.1016/j.yasu.2025.04.012. Epub 2025 Jun 14.
Frequency and Predictors of Axillary Lymph Node Metastases in Iranian Women with Early Breast Cancer.
Sandoughdaran S, Malekzadeh M, Mohammad Esmaeil ME.
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1617-1620. doi: 10.22034/APJCP.2018.19.6.1617.
Life beyond Z11.
Ahmed M, Douek M.
Breast. 2013 Dec;22(6):1226-7. doi: 10.1016/j.breast.2013.07.051. Epub 2013 Aug 26.
The benefits and limitations of sentinel lymph node biopsy.
Amersi F, Hansen NM.
Curr Treat Options Oncol. 2006 Mar;7(2):141-51. doi: 10.1007/s11864-006-0049-y.
